Today's Committee Meetings on the LRL website is a calendar of interim committee hearings with links to agendas. Below are resources related to upcoming Interim Hearings.
August 4, 2022
House Select Committee on Health Care Reform
Charge: Study the implications of excessive health care costs on the efficacy of Texas Medicaid and the private health insurance market and the resulting impact on individual Texans, businesses, and state government.
- Examine the interaction of specific factors of health care affordability such as transparency, competition, and patient incentives. Make recommendations to expand access to health care price information to allow consumers to make informed decisions regarding their care;
- 2020 Health Care Cost and Utilization Report, Health Care Cost Institute, May 2022
- Addressing Cost Drivers in U.S. Healthcare Through Transparency, Competition, and Value, Texas Public Policy Foundation, March 2021
- Barriers to Price and Quality Transparency in Health Care Markets, RAND Corporation, 2021
- Increasing Price Transparency in Health Care: Key Themes and Policy Options from a Technical Expert Panel, RAND Corporation, 2021
- Frequently Asked Questions, Texas Healthcare Costs
- Examine the impact of government benefit, administrative, and contractual mandates imposed upon private insurance companies and their impact on employer and consumer premiums and out-of-pocket costs, including the effects of specific benefit and any-willing-provider requirements. Make recommendations for state and agency-level mandates and regulations that could be relaxed or repealed to increase the availability and affordability of private health coverage options in the state;
- Know Your Coverage: EHBs and Mandated Health Benefits, Office of Public Insurance Counsel, October 13, 2021
- Laws to Curb Surprise Medical Bills Might Be Inflating Health Care Costs, PEW Charitable Trusts, May 20, 2021
- Stabilizing the Individual Health Care Market, National Conference of State Legislatures, March 2020
- Texas Mandated Health Benefits, Texas Department of Insurance, updated to reflect laws in effect as of September 1, 2019
- Review access to and affordability of prescription drugs;
- State Drug Pricing Laws: 2017-2022, National Academy for State Health Policy, updated July 19, 2022
- House Bill 18 Implementation Update: Texas Cares, Texas Health and Human Services, May 17, 2022
- Comparison of State Prescription Drug Affordability Review Initiatives, National Academy for State Health Policy, updated March 31, 2022
- Prescription Drug Price Disclosure Program, Texas Department of State Health Services, last updated January 27, 2022
Charge: Monitor the implementation of, and compliance with, current price transparency requirements and study ways that the state can support patients and increase competition. Make legislative and administrative recommendations, as appropriate;
- Health Facility Compliance Guidance Letter (SB 1137, 87R), Texas Health and Human Services Commission, May 13, 2022
- Are Texas Hospitals Practicing Price Transparency?, Baker Institute for Public Policy, March 21, 2022
- Transparency and Disclosure of Health Care Prices, National Conference of State Legislatures, September 7, 2021
- Semi-Annual Hospital Price Transparency Compliance Report, PatientsRightsAdvocate.org, July 2021
- Hospital Price Transparency, Centers for Medicare and Medicaid Services
Charge: Evaluate innovative, fiscally positive options to ensure that Texans have access to affordable, quality and comprehensive health care, with an emphasis on reaching low-income and at-risk populations. The evaluation should include a study of strategies other states and organizations have implemented or proposed to address health care access and affordability. Make recommendations to increase primary health care access points in Texas.
- Health Innovations State Law Archive Database | 2015-2021, National Conference of State Legislatures, November 15, 2021
- Affordable Care Act Medicaid Expansion, National Conference of State Legislatures, October 14, 2021
- The Effects of Medicaid Expansion Under the ACA: Studies from January 2014 to January 2020, Kaiser Family Foundation, March 17, 2020
- Healthcare Affordability State Policy Scorecard, Altarum Healthcare Value Hub
August 5, 2022
House Committee on Health Care Reform
If the committee does not complete its hearing of all invited testimony scheduled for its August 4th public hearing, it will reconvene after a recess to continue hearing invited testimony only on the posted interim charges.
